Ashley Tyrner-Dolce

Solo Angel New York, NY, United States

About Ashley Tyrner-Dolce

Ashley Tyrner-Dolce is the founder of FarmboxRx and a New York-based solo angel writing $25k-$100k checks at pre-seed and seed in tech-enabled care delivery and consumer wellness, with no AI flag. Her operating role at FarmboxRx (food-as-medicine, Medicare and Medicaid food benefits delivery) gives her distinctive pattern recognition on the food-and-health intersection, SDOH, and Medicare and Medicaid supplemental benefits. Founders building food-as-medicine, SDOH-focused care delivery, or companies that touch Medicare and Medicaid supplemental benefits programs where her FarmboxRx operating context adds meaningful value are the natural fit. She is the wrong audience for biotech, devices, B2B healthcare software outside the SDOH-and-food vertical, AI-heavy plays, or commercial-only consumer wellness without a clinical or program angle. The small check size positions her as a high-signal SDOH-specialist angel rather than a meaningful capital source, and her real value to a cap table is access to the food-as-medicine ecosystem, payor relationships in the supplemental-benefits space, and her own operating playbook. Outreach via LinkedIn is the primary channel; warm introductions through the SDOH and food-as-medicine community, fellow Medicare and Medicaid supplemental-benefits operators, or NY healthcare networks materially help. Best treated as a niche but credible SDOH-and-food-as-medicine specialist angel.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.
Portfolio data coming soon. Know their portfolio? Suggest an edit →
Team information coming soon. Know the partners? Suggest an edit →

Pitch / review this investor

Have you raised from Ashley Tyrner-Dolce? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.